Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

AGE Antikörper

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch AGE in ELISA. Es zeigt Reaktivität gegenüber Proben von Human.
Produktnummer ABIN5680158
-15% Promotion 2026
1.551,97 €
1.825,85 €
Sparen Sie 273,88 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
1 mg
Lieferung nach: Deutschland
Lieferung in 2 bis 4 Werktagen

Kurzübersicht für AGE Antikörper (ABIN5680158)

Target

Alle AGE Antikörper anzeigen
AGE (Advanced Glycation End Products (AGE))

Reaktivität

  • 21
  • 16
  • 16
  • 5
  • 4
  • 3
  • 3
Human

Wirt

  • 23
  • 4
  • 1
Kaninchen

Klonalität

  • 24
  • 4
Polyklonal

Konjugat

  • 9
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser AGE Antikörper ist unkonjugiert

Applikation

  • 24
  • 14
  • 13
  • 13
  • 10
  • 6
  • 5
  • 4
  • 3
  • 3
ELISA
  • Spezifität

    Advanced Glycation End Products (AGE), cross-reactivity BSA-AGE, HSA-AGE <1 %

    Kreuzreaktivität (Details)

    Human, rat. Broad reactivity with advanced glycation end products (AGE) in many species.

    Produktmerkmale

    This antibody is suitable for the detection of different AGE products in tissues, tissue extracts and body fluids. Long-term incubation of proteins with glucose leads, through Schiff's base and Amadori rearrangement products, to the formation of advanced glycation end products (AGE) which are characterized by fluorescence, brown color and inter- and intra-molecular cross-linking. Recent immunological studies using anti-AGE antibodies demonstrated the presence of AGE in (i) human lens, (ii) renal proximal tubules in patients with diabetic nephropathy and chronic renal failure, (iii) atherosclerotic lesions of arterial walls, (iv) ß2-microglobulin of carpal tunnel amyloid fibril deposits in patients with hemodialysis-related amyloidosis and (v) brain tissues of patients with Alzheimer's disease. These results suggested the potential role of AGE in normal aging and age-enhanced disease processes. Advanced Glycation End Products (AGE), cross-reactivity BSA and HSA <1 % .

    Aufreinigung

    Protein A affinity purified IgG

    Immunogen

    Advanced Glycation End Products /BSA/HSA

    Isotyp

    IgG
  • Applikationshinweise

    human lens, arteriosclerotic plaques,ELISA, IHC not established,60 min at RT or 18 hr at 2-8 °C,(liquid conc.) ELISA app. 1 μg/mL, (IHC 5-10 μg/mL)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    PBS 0.05 M,  pH 7.15, 0.85 % NaCl, 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C
  • Target

    AGE (Advanced Glycation End Products (AGE))

    Andere Bezeichnung

    AGE, Advanced Glycation End Products

    Substanzklasse

    Chemical
Sie sind hier:
Chat with us!